Endometrial Cancer: Biomarker Testing, Treatment Options & Genetic Testing Explained

Learn about biomarker and genetic testing for endometrial cancer from leading experts at MD Anderson and UC San Diego. This comprehensive webinar covers treatment options, precision medicine approaches, immunotherapy advances, and clinical trial opportunities for endometrial cancer patients. ⏱️ TIMESTAMPS: 0:00 Introduction & Welcome 1:08 OCRA Mission & Support Programs 3:31 AstraZeneca: Innovation in Endometrial Cancer Treatment 6:10 Dr. Klopp: Endometrial Cancer Overview & Biomarker Testing 26:20 Endometrial Cancer Causes & Risk Factors 28:10 Where Endometrial Cancer Starts in the Body 29:50 Genetic Testing: When & Why It Matters 31:30 Biomarker Testing After Diagnosis Explained 33:00 Screening Recommendations for Family History 34:50 Understanding Metastasis & Recurrence 36:00 Imaging: CT Scans vs. PET Scans 37:50 Reading Your Pathology & Tissue Reports 38:40 Diet, Supplements & Lifestyle Considerations 40:00 Standard of Care: Chemotherapy & Radiation 42:40 Dr. Eskander: Precision Medicine & Targeted Therapies 1:07:20 Recognizing Endometrial Cancer Symptoms 1:09:30 Platinum-Based Treatments & Future Directions 1:12:00 Post-Treatment Monitoring for Recurrence 1:13:20 ctDNA Testing & Signatera Explained 1:15:00 Maintenance Therapies: What to Know 1:17:00 Keytruda & Immunotherapy Advances 1:19:50 When Radiation Therapy Is Recommended 1:21:40 Comparing Recurrent Ovarian & Endometrial Cancer 1:24:30 Variants of Unknown Significance (VUS) Explained 1:25:40 Ovary & Fallopian Tube Removal Considerations 1:27:20 The Future of Precision Medicine in Treatment 🔬 IN THIS VIDEO: This educational seminar was hosted by the Ovarian Cancer Research Alliance (OCRA) on April 9th, featuring two leading gynecologic oncology experts. Dr. Ann Klopp is a radiation oncologist at The University of Texas MD Anderson Cancer Center ‪@mdanderson‬ specializing in gynecologic cancers. Dr. Ramez Eskander is a gynecologic oncologist at UC San Diego Health Moores Cancer Center ‪@UCSDHealth‬ focused on precision medicine approaches. The discussion covers critical information for endometrial cancer patients and caregivers, including how genetic and biomarker testing shape treatment decisions, emerging targeted therapies, immunotherapy advances, and navigating clinical trial options. Both doctors answered live questions from attendees, addressing real patient concerns about diagnosis, treatment, and survivorship. This event was made possible with support from AstraZeneca and Merck. 💙 ABOUT OCRA: Ovarian Cancer Research Alliance (OCRA) is the world's largest organization combating ovarian and all gynecologic cancers through groundbreaking research, impactful advocacy, and unparalleled patient support. To date,OCRA has invested $137 million in research initiatives, funding discoveries and creating new treatments. We are the only dedicated voice for the gynecologic cancer community on Capitol Hill and provide support programs for patients and families when they need it most. Learn more: https://ocrahope.org 🔔 Subscribe to OCRA's channel for the latest research updates, patient education, and expert interviews:    / @ocrahope   #EndometrialCancer #BiomarkerTesting #GeneticTesting #GynecologicCancer #PrecisionMedicine #Immunotherapy #CancerTreatment #ClinicalTrials #OCRAHope